121 related articles for article (PubMed ID: 2749611)
1. Prevention of the formation of arterial thrombi using different antiplatelet drugs: experimental study in dogs.
Escudero-Vela MC; Alvarez L; Rodríguez V; del Moral JH; Millán I; Castillo-Olivares JL
Thromb Res; 1989 May; 54(3):187-95. PubMed ID: 2749611
[TBL] [Abstract][Full Text] [Related]
2. [Use of aspirin in the primary prevention of vascular thrombi. A comparative study with other anti-aggregant drugs].
Escudero MC; Alvarez L; Rodríguez V; de Haro J; Millán I; Castillo-Olivares JL
Rev Esp Cardiol; 1989 Oct; 42(8):536-40. PubMed ID: 2602610
[TBL] [Abstract][Full Text] [Related]
3. [Thrombosis from prosthetic materials: prevention with different antiaggregatory agents. Low dose aspirin?].
Escudero MC; Alvarez L; Rodríguez V; de Haro J; Millán I; Torres MT; Jorge E; Castillo-Olivares JL
Rev Esp Cardiol; 1990; 43(6):385-91. PubMed ID: 2146720
[TBL] [Abstract][Full Text] [Related]
4. Prevention of thrombus formation on biomaterials exposed to blood using different antiplatelet drugs: experimental study in dogs.
Escudero MC; Alvarez L; de Haro J; Millán I; Jorge E; Castillo-Olivares JL
J Biomed Mater Res; 1994 Jan; 28(1):1-6. PubMed ID: 8126020
[TBL] [Abstract][Full Text] [Related]
5. Prevention of arterial thrombosis by a monoclonal antibody against the 100 to 109 amino acid sequence stretch of the beta-subunit of the human platelet fibrinogen receptor: a comparative study with low dose aspirin.
Escudero C; Alvarez L; de Haro J; González J; Alvarez MV; Millán I; Jorge-Herrero E; Castillo-Olivares JL
J Am Coll Cardiol; 1994 Feb; 23(2):483-6. PubMed ID: 8294704
[TBL] [Abstract][Full Text] [Related]
6. Effects of triflusal and acetylsalicylic acid on microthrombi formation in experimental brain ischemia.
Heye N; Campos A; Kannuki S; Cervós-Navarro J
Exp Pathol; 1991; 41(1):31-6. PubMed ID: 2022253
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction.
Müller TH
Neurology; 2001; 57(5 Suppl 2):S8-S11. PubMed ID: 11552048
[TBL] [Abstract][Full Text] [Related]
8. Are agents affecting platelet functions clinically useful?
Verstraete M
Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
[TBL] [Abstract][Full Text] [Related]
9. Triflusal versus acetylsalicylic acid: a double-blind study for the prophylaxis of deep vein thrombosis after hip surgery.
Putz P; Buyse H; Delvaux D; Kutnowski M; Demulder A; Dumont N; Lavenne E; Claes R; Rosillon D
Acta Chir Belg; 1991; 91(6):269-76. PubMed ID: 1781229
[TBL] [Abstract][Full Text] [Related]
10. Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors.
Haskel EJ; Adams SP; Feigen LP; Saffitz JE; Gorczynski RJ; Sobel BE; Abendschein DR
Circulation; 1989 Dec; 80(6):1775-82. PubMed ID: 2513145
[TBL] [Abstract][Full Text] [Related]
11. Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin.
Josa M; Lie JT; Bianco RL; Kaye MP
Am J Cardiol; 1981 Jun; 47(6):1248-54. PubMed ID: 6972158
[TBL] [Abstract][Full Text] [Related]
12. Effects of triflusal on arteriosclerosis progression assessed with high-resolution arterial ultrasound.
Cesarone MR; Laurora G; DeSanctis MT; Incandela L; Fugazza L; Girardello R; Poli A; Peracino L; Ambrosoli L; Belcaro G
Angiology; 1999 Jun; 50(6):455-63. PubMed ID: 10378821
[TBL] [Abstract][Full Text] [Related]
13. [Antiplatelet drugs and prevention of aortocoronary bypass occlusion].
Davì G; Botindari G; Catalano I; Strano A
Cardiologia; 1988 Feb; 33(2):123-6. PubMed ID: 3282656
[No Abstract] [Full Text] [Related]
14. Antiplatelet therapy.
Schafer AI
Am J Med; 1996 Aug; 101(2):199-209. PubMed ID: 8757361
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
[TBL] [Abstract][Full Text] [Related]
16. [Double-blind study for the prevention of postoperative thrombosis].
Encke A; Stock C; Dumke HO
Chirurg; 1976 Dec; 47(12):670-3. PubMed ID: 1001131
[TBL] [Abstract][Full Text] [Related]
17. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
18. Triflusal.
McNeely W; Goa KL
Drugs; 1998 Jun; 55(6):823-33; discussion 834-5. PubMed ID: 9617597
[TBL] [Abstract][Full Text] [Related]
19. [Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE].
Alvarez-Sabín J; Montaner-Villalonga J
Rev Neurol; 1999 Oct 16-31; 29(8):780-4. PubMed ID: 10560115
[TBL] [Abstract][Full Text] [Related]
20. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Jamieson DG; Parekh A; Ezekowitz MD
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
